OceanIQ Capital’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
OceanIQ Capital's ABBV Position: Q3 2026 in Review
OceanIQ Capital increased its AbbVie (ABBV) stake by 0.68% in Q3 2026, buying an estimated $14.9K and bringing the position to 8,646 shares worth $2.37M. The position accounts for 1.25% of the portfolio, ranked #15.
OceanIQ Capital first reported a position in ABBV in Q2 2026 and has held it in 2 quarters since. 4,281 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- OceanIQ Capital held 8,646 shares of AbbVie worth $2.37M as of Q3 2026.
- OceanIQ Capital bought 58 AbbVie shares in Q3 2026, an estimated $14.9K.
- AbbVie made up 1.25% of OceanIQ Capital's portfolio in Q3 2026, its #15 holding.
- OceanIQ Capital first reported a position in AbbVie in Q2 2026 and has held it in 2 quarters since.
- 4,281 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on OceanIQ Capital's 13F filing for Q3 2026, filed 19 Oct 2026.